Ro vs Wellorithm: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
Wellorithm beats Ro overall, scoring 7.4/10 vs 7.2/10. Wellorithm is more affordable at $147/mo vs $149/mo. Choose Ro for users who want fda-approved brand-name glp-1 access includin. Choose Wellorithm for cash-pay patients who want compounded semaglutide or tirzepa.
A side-by-side comparison of Ro and Wellorithm covering pricing, scores, medication types, insurance, and more to help you decide.
Ro
#40 of 46One of the most recognized telehealth brands, now restructured: Ro Body membership ($149/mo ongoing or $74/mo annual prepay) is priced separately from medication. Added Foundayo (Eli Lilly's FDA-approved oral GLP-1 launched April 6, 2026) alongside Wegovy, Zepbound, Ozempic, and Mounjaro.
Visit RoWellorithm
#30 of 46Telehealth platform for compounded semaglutide and tirzepatide that uniquely offers BOTH injectable and oral dissolving tablet formats, paired with a 10% weight-loss guarantee that refunds up to four months of program fees if the patient does not lose at least 10% of baseline weight after 16 weeks of medication adherence (terms apply). 28-day recurring billing, non-refundable per-cycle, with a documented address listed in Berlin, Germany.
Visit Wellorithm| Feature | Ro | Wellorithm |
|---|---|---|
| Our Score | 7.2/10 | 7.4/10 |
| Starting Price | $149/mo | $147/mo |
| Medication Type | Brand | Compounded |
| Insurance Accepted | Yes | No |
| Best For | Users who want FDA-approved brand-name GLP-1 access including the new Foundayo (orforglipron) oral pill, with direct insurance billing | Cash-pay patients who want compounded semaglutide or tirzepatide with the option of oral dissolving tablets (rare), a 10% weight-loss money-back guarantee, and 24/7 support — and who are comfortable enrolling with a platform that does not publicly disclose its founders, headquarters, or named prescribers |
| Ranking | #40 | #30 |
Pros & Cons Compared
Ro
Pros
- +Carries Foundayo (orforglipron) — Eli Lilly's FDA-approved oral GLP-1 launched April 6, 2026 — at $149-299/mo via LillyDirect matching
- +Direct insurance billing with major carriers — with coverage, Wegovy or Zepbound can cost $0-25/mo copay
- +Ro Body membership: $39 first month, $149/mo ongoing, or $74/mo on annual prepay ($100/mo savings)
- +Claims matched pricing with LillyDirect, NovoCare, and TrumpRx — some of the lowest cash brand prices available
Cons
- −Membership and medication are billed separately — readers need to add them together for the all-in monthly cost
- −Brand-name only — no compounded semaglutide or tirzepatide (compounded 'limited' footnote from prior years is not reliably offered now)
- −Without insurance, brand-name meds stack on top of the $149 membership ($199+ intro, $349+ ongoing for Wegovy injection)
Wellorithm
Pros
- +Compounded GLP-1 available in BOTH injectable AND oral dissolving tablet formats — semaglutide and tirzepatide each in two formats — broader format menu than most compounded-only platforms
- +10% weight-loss money-back guarantee: patients who don't lose at least 10% of baseline weight after 16 weeks of medication adherence may be eligible for refund of up to four months of program fees (verified weight documentation required)
- +Competitive entry pricing — $147/mo compounded semaglutide and $249/mo compounded tirzepatide put Wellorithm near the cheaper end of the compounded market
- +2-minute qualification quiz, virtual consultation, 24/7 support availability claimed
- +23,000+ reviews and 4.9-star rating reported (volume is unusually high for this market segment — verify on independent third-party sources before relying on it)
- +Spring promotion advertised at $147 with free shipping included
Cons
- −Founding year, corporate ownership, and named prescribers are NOT publicly disclosed — the only address listed is a German one (Berlin, DE 81566), unusual for a platform serving US patients
- −49 states only — service is unavailable in Louisiana and outside the United States
- −28-day recurring billing cycle with payments non-refundable once processed — strict cancellation policy and no proration for partial months
- −Compounded-only — no FDA-approved Wegovy, Zepbound, Ozempic, Mounjaro, or Foundayo; FDA does not review compounded medications for safety, effectiveness, or manufacturing quality
- −Weight-loss guarantee terms are restrictive: requires verified weight documentation (doctor attestation or video evidence), prior medication history disclosure, consistent dosing adherence, and refund processed within 30 days of approval — only fees actually paid are refundable, baseline payments remain non-refundable
- −Two different affiliate landing pages (campaign-7 and qoroxapi/lead.php direct route) with different funnel structures suggest the platform tests multiple lead-capture flows, which can create inconsistent post-click experiences
Our Verdict
Wellorithm edges out Ro with a score of 7.4/10 vs 7.2/10. If budget is your priority, Wellorithm starts at $147/mo compared to Ro's $149/mo. Ro accepts insurance, which can significantly reduce your out-of-pocket costs. Choose Ro if you want: users who want fda-approved brand-name glp-1 access including the new foundayo (orforglipron) oral pill, with direct insurance billing. Choose Wellorithm if you want: cash-pay patients who want compounded semaglutide or tirzepatide with the option of oral dissolving tablets (rare), a 10% weight-loss money-back guarantee, and 24/7 support — and who are comfortable enrolling with a platform that does not publicly disclose its founders, headquarters, or named prescribers.